Krsnaa Diagnostics Limited

NSE KRSNAA.NS

Krsnaa Diagnostics Limited EBIT for the year ending March 31, 2024: USD 10.37 M

Krsnaa Diagnostics Limited EBIT is USD 10.37 M for the year ending March 31, 2024, a -3.04% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Krsnaa Diagnostics Limited EBIT for the year ending March 31, 2023 was USD 10.69 M, a -22.66% change year over year.
Krsnaa Diagnostics Limited EBIT for the year ending March 31, 2022 was USD 13.83 M, a -68.49% change year over year.
Krsnaa Diagnostics Limited EBIT for the year ending March 31, 2021 was USD 43.89 M, a 347.45% change year over year.
Krsnaa Diagnostics Limited EBIT for the year ending March 31, 2020 was USD -17.74 M, a -111.95% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

NSE: KRSNAA.NS

Krsnaa Diagnostics Limited

CEO	Mr. Mitesh Dave
IPO Date	Aug. 16, 2021
Location	India
Headquarters	S.No.243,A-Hissa No.6/6
Employees	3,700
Sector	Healthcare
Industries Telehealth Biotechnology Dental Care Drugstores & Retail Pharmacies Hospitals & Clinics Medical Instruments Pharmaceuticals Utilities

Description

Krsnaa Diagnostics Limited provides diagnostic services. The company offers a range of technology-enabled diagnostic services, such as radiology, pathology/clinical laboratory, and tele-radiology services to public and private hospitals, medical colleges, and community health centers. As of December 31, 2020, it operated 1,801 diagnostic centers in 13 states across India. The company was incorporated in 2010 and is based in Pune, India.

Key trends

Past 5 years